Marshall Wace North America’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,255
| Closed | -$1.01M | – | 1485 |
|
|
2019
Q3 | $1.01M | Sell |
16,255
-486
| -3% | -$30.1K | 0.01% | 689 |
|
|
2019
Q2 | $754K | Sell |
16,741
-374
| -2% | -$16.8K | ﹤0.01% | 813 |
|
|
2019
Q1 | $1.08M | Sell |
17,115
-10,393
| -38% | -$653K | 0.01% | 649 |
|
|
2018
Q4 | $1.48M | Sell |
27,508
-41,951
| -60% | -$2.26M | 0.01% | 516 |
|
|
2018
Q3 | $6.97M | Buy |
69,459
+17,309
| +33% | +$1.74M | 0.05% | 262 |
|
|
2018
Q2 | $3.44M | Sell |
52,150
-9,984
| -16% | -$659K | 0.02% | 610 |
|
|
2018
Q1 | $3.11M | Buy |
62,134
+2,801
| +5% | +$140K | 0.02% | 688 |
|
|
2017
Q4 | $2.87M | Sell |
59,333
-1,255
| -2% | -$60.7K | 0.02% | 736 |
|
|
2017
Q3 | $3.88M | Sell |
60,588
-11,388
| -16% | -$729K | 0.02% | 621 |
|
|
2017
Q2 | $5.18M | Buy |
71,976
+17,955
| +33% | +$1.29M | 0.04% | 491 |
|
|
2017
Q1 | $3.46M | Buy |
+54,021
| New | +$3.46M | 0.03% | 474 |
|